** Shares of healthcare products distributor Henry Schein HSIC.O rise 6.2% to $73.09
** Activist investor Ananym Capital Management is urging Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business
** Ananym argues that Schein needs new board members and ultimately a new CEO to tackle spending, according to a Reuters report
** Ananym says medical distribution business sale could increase stock price by 20%
** Including session's move, stock down 2.1% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.